PMID- 2207334 OWN - NLM STAT- MEDLINE DCOM- 19901119 LR - 20210216 IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 76 IP - 8 DP - 1990 Oct 15 TI - The role of cellular maturation in neutrophil heterogeneity. PG - 1639-46 AB - Previous studies have shown that many neutrophil (PMN) characteristics are heterogeneous but the origin of PMN heterogeneity is unknown. It is unclear if PMN functional heterogeneity is secondary to maturational differences or due to distinct subpopulations of cells that possess different functional capacities. The PMN 31D8 antigen is a useful probe for evaluation of PMN subpopulations. The majority of PMNs (approximately 85%) exhibit a high intensity fluorescence after 31D8 monoclonal antibody (MoAb) labeling (31D8 enriched or "bright" PMNs) as determined by flow cytometric analysis. These cells are more functional than cells with low intensity fluorescence (31D8 diminished or "dull" PMNs). Various immunologic, clonogenic and functional techniques were used to study the expression of the 31D8 antigen in HL-60 cells and myeloid cells in order to evaluate antigenic and functional heterogeneity during morphologic maturation. The results of this study indicate that the percentage of 31D8 antigen positive (31D8 antigen enriched and diminished) bone marrow cells increases from 20 +/- 11% in myeloblast cells to 68 +/- 10% in promyelocytes, 93 +/- 2% in myelocytes and 99 +/- 1% in bands and PMNs. 31D8 antigen enriched cells first appear at the myelocyte stage (32 +/- 10%) and increase in bands (52 +/- 13%), marrow PMNs (62 +/- 13%) and peripheral blood PMNs (88 +/- 4%). These data indicate that the heterogeneous expression of 31D8 antigen in PMNs is due, at least in part, to maturational differences within the PMN population and raise the possibility that other heterogeneously expressed PMN characteristics are also maturationally derived. They also suggest that 31D8 antigenic expression may be a more precise indicator of myeloid functional maturation than maturation as identified by cellular morphology. FAU - Krause, P J AU - Krause PJ AD - Department of Pediatrics, Hartford Hospital, CT 06115. FAU - Todd, M B AU - Todd MB FAU - Hancock, W W AU - Hancock WW FAU - Pastuszak, W T AU - Pastuszak WT FAU - Maderazo, E G AU - Maderazo EG FAU - Hild, D H AU - Hild DH FAU - Kosciol, C M AU - Kosciol CM LA - eng GR - CA 08341/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Antigens, Surface) SB - IM MH - Antigens, Surface/analysis MH - Bone Marrow Cells MH - Cell Survival MH - Cells, Cultured MH - Flow Cytometry MH - Fluorescent Antibody Technique MH - Histocytochemistry MH - Humans MH - Immunoenzyme Techniques MH - Immunophenotyping MH - Leukemia, Promyelocytic, Acute/immunology/pathology MH - Neutrophils/*cytology/immunology MH - Tumor Cells, Cultured EDAT- 1990/10/15 00:00 MHDA- 1990/10/15 00:01 CRDT- 1990/10/15 00:00 PHST- 1990/10/15 00:00 [pubmed] PHST- 1990/10/15 00:01 [medline] PHST- 1990/10/15 00:00 [entrez] AID - S0006-4971(20)75238-9 [pii] PST - ppublish SO - Blood. 1990 Oct 15;76(8):1639-46.